Home › Funds › Zeit Capital LLC › ABT

Zeit Capital LLC position in ABT

ABBOTT LABS · Health Care

Zeit Capital LLC reported holding 116 shares of ABT (ABBOTT LABS) in its Q2 2026 13F filing — a position valued at US$11K, representing 0.01% of its reported portfolio and ranking #47 among its reported holdings. Zeit Capital LLC has disclosed ABT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)116 sh
Reported value held$10.53K
Portfolio Weight0.01%
First reportedQ1 2026
Last changeNew

How Zeit Capital LLC's ABT position evolved

Zeit Capital LLC first disclosed a stake in ABT in Q1 2026 at 116 shares (US$12K). Across 2 filings, Zeit Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 116 shares valued at US$11K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 116 $11.91K New
Q2 2026 116 $10.53K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABS) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), BlackRock Inc (US$13.84B), VANGUARD CAPITAL MANAGEMENT LLC (US$10.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →